References
Milne RI, Heaton-Brown KH, Cubitt A, et al. Quality-of-life valuations of advanced breast cancer by New Zealand women. Pharmacoeconomics 2006; 24 (3): 281–292
Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine: Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276 (14): 1172–1177
Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276 (15): 1253–1258
Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses: Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996 Oct 23–30; 276 (16): 1339–1341
Pagano M, Gauvreau K. Principles of biostatistics. Belmont (CA); Duxbury Press, 1993
Tsevat J, Weeks JC, Guadagnoli E, et al. Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med 1994; 9: 576–582
Acknowledgements
The author would like to acknowledge H.S. Wieand and P.A. Ganz for useful discussions. There was no grant support and there are no conflicts of interest related to this work.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Land, S. Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women. Pharmacoeconomics 24, 415–416 (2006). https://doi.org/10.2165/00019053-200624040-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200624040-00010